Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2026-01-14 @ 10:17 AM
Study NCT ID:
NCT05626569
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2022-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
Sponsor:
Organization: